Letermovir for Cytomegalovirus Prophylaxis in Patients With T-PLL Treated With Alemtuzumab.

Campath (alemtuzumab) - Sanofi

Prevymis (letermovir) - Merck (MSD)

http://www.ncbi.nlm.nih.gov/pubmed/42502036

Basem M William; Catherine G Chung; John C Reneau; Jonathan E Brammer; Walter Hanel; Ying Huang; Zachary Braunstein

Jul 26, 2026